doc_id,table_id,row_index,ColumnA,ColumnB,ColumnC,ColumnD,ColumnE,ColumnF,ColumnG,ColumnH,ColumnI,ColumnJ,ColumnK
WHO_TB_handbook_module3_diagnosis_2025,Table 2.6.,1,Class of test,Test,Manufacturer,Platform,Gene target(s),DST,Time to results,Recommendations,Infrastructure requirements,Batch size,Number of tests per 8-hour shift
WHO_TB_handbook_module3_diagnosis_2025,Table 2.6.,2,LC- aNAATs,Xpert MTB/ XDR,Cepheid,"GeneXpert I, II, IV, XVI, requires 10-colour module","inhA , katG , fabG1 , oxyR- aphC , gyrA , gyrB , Rrs , eis","INH, ETO, FQ and AMK",90 min,"Follow-on detection of resistance to INH, ETO, FQ and second- line injectable drugs","Stable electricity, ambient temperature not above 25° C",Single sample per test,3–4 per module
WHO_TB_handbook_module3_diagnosis_2025,Table 2.6.,3,LPAs,GenoType MTBDR plus,Bruker- Hain,,"rpoB , katG , inhA ,","RIF, INH",1–2 days,Follow-on detection of resistance to RIF and INH,"Thermocycler, incubation solution, stable electricity, ambient temperature, clean room for DNA amplification steps","Single test, 12 or 48",Depends on laboratory capacity
WHO_TB_handbook_module3_diagnosis_2025,Table 2.6.,4,,GenoType MTBDR sl,Bruker- Hain,,"gyrA , gyrB , rrs , eis","FQ, AMK",1–2 days,Follow-on detection of resistance to FQ and AMK,"Thermocycler, incubation solution, stable electricity, ambient temperature, clean room for DNA amplification steps","Single test, 12 or 48",Depends on laboratory capacity
WHO_TB_handbook_module3_diagnosis_2025,Table 2.6.,5,,Genoscholar NTM+MDRTB II,Nipro,,"rpoB , katG , inhA","RIF, INH",1–2 days,Follow-on detection of resistance to RIF and INH,"Thermocycler, incubation solution, stable electricity, ambient temperature, clean room for DNA amplification steps","Single test, 12 or 48",Depends on laboratory capacity
WHO_TB_handbook_module3_diagnosis_2025,Table 2.6.,6,HC- rNAAT,Genoscholar PZA-TB,Nipro,,pncA,PZA,1–2 days,Follow-on detection of resistance to PZA,"Thermocycler, incubation solution, stable electricity, ambient temperature, clean room for DNA amplification steps","Single test, 12 or 48",Depends on laboratory capacity
WHO_TB_handbook_module3_diagnosis_2025,Table 2.6.,7,Targeted NGS,Deeplex Myc -TB,Genoscreen,"Illumina iSeq , MiniSeq , MiSeq etc.",*,"RIF, INH, PZA, EMB, FQ, BDQ, LZD, CFZ, AMK and STR",48+ h,"Follow-on detection of resistance to INH, FQ, BDQ, LZD, CFZ, PZA, EMB, AMK and STR in drug-susceptible TB or MDR/RR-TB patients","Thermocycler, sequencer, powerful computing system for data analysis, high-speed internet connection",13 up to 1200 samples depending on the instrument used,Depends on laboratory capacity
WHO_TB_handbook_module3_diagnosis_2025,Table 2.6.,8,,AmPORE - TB,Oxford Nanopore Technologies,MinION,**,"RIF, INH, PZA, FQ, BDQ, LZD, CFZ, AMK and STR",5 h,"Follow-on detection of resistance to RIF, INH, FQ, LZD, AMK and STR in MDR/ RR-TB patients","Thermocycler, sequencer , powerful computer for data analysis, high-speed internet connection",22 samples excluding controls per flow cell,Depends on laboratory capacity
WHO_TB_handbook_module3_diagnosis_2025,Table 2.6.,9,,Tbseq,Shen Ting Biotech,"Illumina iSeq , MiniSeq , MiSeq etc.","embB , embA",EMB,12 h,Follow-on detection of resistance to EMB in MDR/RR-TB patients,"Thermocycler, sequencer , powerful computer for data analysis, high-speed internet connection",13 up to 1200 samples depending on the instrument used,Depends on laboratory capacity